South San Francisco, CA, USA – Cellares, the first Integrated Development and Manufacturing Organization (IDMO), announces multiple strategic technology partnerships to advance the Cell Q™, the first fully automated quality control testing platform purpose-built to match the commercial-scale throughput for cell therapy manufacturing. Cellares is unveiling these partnerships ahead of the 10th Annual CAR-TCR Summit, […]

LIVERMORE, Calif. — Today, Precision Cell Systems (PCS) announced its official launch following the strategic acquisitions of S2 Genomics and ORFLO, creating a unified company that addresses critical bottlenecks in cell analysis workflows. PCS launches with significant market traction: over 1,000 installed instruments, more than 700 active customers, and a technology portfolio validated by over 500 […]

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the placement of the 1,000th BD Rhapsody™ System, a flagship instrument for single-cell multiomics analysis, at Addenbrooke’s Hospital of the University of Cambridge, United Kingdom. Together with its comprehensive menu of assays for DNA, RNA, and protein […]

Tempe, AZ — Biosensing Instrument Inc (BI) introduces today SPRm 220, a new cell-based surface plasmon resonance (SPR) system.  Building on the award-winning SPR microscopy technology first launched in 2017, the SPRm 220 brings enhanced throughput, improved usability, and unmatched capability in label-free, cell-based kinetic analysis. Designed specifically for the challenges of membrane protein research, […]

Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, has announced the launch of its Microbial Amplicon Barcoding Kit 24 V14, to enable faster and more flexible microbial analysis in a single workflow. Oxford Nanopore’s new kit has been optimised to provide an information-rich, rapid, and accessible full-length amplicon […]

RiboMarker-NextGen Biomarker Discovery SANTA CRUZ, CA, UNITED STATES — RealSeq Biosciences, a pioneer in RNA-based diagnostics, today announced it has received a Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) (FAIN# R44HG013284; Federal Award Date: August 15, 2025). This highly competitive award provides multi-year, non-dilutive funding to accelerate […]

New formats redefine molecular assay development by cutting refrigeration costs, simplifying logistics, and ensuring uncompromised performance at room temperature. CINCINNATI — The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of the industry’s first liquid qPCR master mixes proven stable for over […]

The Board of Directors has with immediate effect among its members elected Maria Rankka to serve as Board Chair of BICO Group AB, until a new chair has been elected by the shareholders’ meeting. Maria Rankka succeeds Rolf Classon who, for health reasons, has chosen to resign from his position on the board and as […]

Strategic expansion with trusted partner enhances customer reach HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), a leading provider of innovative laboratory equipment, is pleased to announce the expansion of its distribution agreement with Fisher Scientific, a part of Thermo Fisher Scientific, one of the world’s largest and most trusted […]

Stockholm, Sweden – Atlas Antibodies proudly announces the launch of AtlasPlex, a complete and customizable multiplex immunohistochemistry (mIHC-IF) solution for FFPE and fresh-frozen tissue. “AtlasPlex marks a significant milestone in Atlas Antibodies’ innovation journey with a strong dedication to preserving and advancing the legacy of the Human Protein Atlas. It’s a testament to what focused innovation and […]